Posted by Michael Wonder on 31 Jul 2021
Schedule of Pharmaceutical Benefits - 1 August 2021
1 August 2021 - The August 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The August issue of the Schedule includes a few new/revised listings:
- Alirocumab (Praluent) - new medicine
- Fremanzeumab (Ajovy) - new medicine'
- Pembrolizumab (Keytruda) - new indication
- Risdiplam (Evrysdi) - new medicine
